Zosano Pharma (NASDAQ:ZSAN – Get Rating) released its quarterly earnings results on Friday. The biotechnology company reported ($1.76) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.75) by ($0.01), Fidelity Earnings reports. Zosano Pharma had a negative return on equity of 80.12% and a negative net margin of 3,812.10%. Zosano Pharma stock […]
StockNews.com initiated coverage on shares of Zosano Pharma (NASDAQ:ZSAN – Get Rating) in a research note published on Monday morning. The firm issued a sell rating on the biotechnology company’s stock. Separately, BTIG Research downgraded shares of Zosano Pharma from a buy rating to a neutral rating in a research report on Wednesday, February 23rd. […]
StockNews.com began coverage on shares of Zosano Pharma (NASDAQ:ZSAN – Get Rating) in a report issued on Sunday. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, BTIG Research downgraded Zosano Pharma from a buy rating to a neutral rating in a report on Wednesday, February 23rd. Shares of ZSAN stock opened […]
StockNews.com began coverage on shares of Zosano Pharma (NASDAQ:ZSAN – Get Rating) in a report issued on Saturday. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, BTIG Research downgraded Zosano Pharma from a buy rating to a neutral rating in a report on Wednesday, February 23rd. Zosano Pharma stock opened at […]
Analysts predict that Zosano Pharma Co. (NASDAQ:ZSAN – Get Rating) will post earnings per share of ($0.08) for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Zosano Pharma’s earnings. Zosano Pharma also reported earnings of ($0.08) per share during the same quarter last year. The firm is scheduled to issue […]